Also from this source


22 Jun, 2017, 15:52 ET AbbVie Declares Quarterly Dividend

You just read:

AbbVie's HUMIRA® (adalimumab) Receives CHMP Positive Opinion to Treat Certain Forms of Non-Infectious Uveitis, a Disease that Can Severely Impact Vision[1]

News provided by

AbbVie

27 May, 2016, 07:00 ET